Healthcare communications studio
Meridian Bridge is a specialist healthcare communications studio. We work with life-sciences and healthcare organisations on the content that shapes how their science is understood — by investors, by regulators, and by the patients at the centre of it.
Why plain language matters
Regulators and funders have formalised the expectation. The EU Clinical Trials Regulation, ICH guidelines, and major global funders including Wellcome and the NIH now require plain-language summaries of trial results as a condition of approval and continued funding. Producing documents that meet those standards — consistently, across languages and geographies — is increasingly a core operational need rather than an afterthought.
For patients, the connection is straightforward. When people understand their diagnosis, their treatment options, and what participation in a trial involves, they make better decisions and follow through more reliably. Patient-facing documents written at an appropriate reading level aren't just a compliance requirement — they reflect how seriously an organisation takes the people it serves.
For investors, the same principle applies differently. A pipeline narrative written for a scientific audience rarely moves capital. Translating what the data means — its implications, its context, its honest risk profile — into language that supports investment decisions is a distinct skill, and one that sits at the heart of what Meridian Bridge does.
What we do
01
Pipeline summaries, fundraising narratives, annual report clinical sections, and CEO communications around data readouts. We help life-sciences organisations frame their science in the language that investors and strategic partners use to make decisions — clearly, credibly, and without losing what makes the underlying work compelling.
02
Patient information leaflets, informed consent forms, and plain-language summaries of trial results, written to the standard that global regulators and major funders now require. Good patient-facing writing respects the reader's intelligence while meeting them where they are — and increasingly, the regulatory bar reflects that expectation.
03
Content for healthcare professionals, disease-awareness programmes, internal scientific communications, and broader campaign work. We bring enough scientific literacy to engage with the material seriously, and enough communication experience to shape it for the people who need to act on it — whether that audience is clinical, commercial, or public.
Our approach
Meridian Bridge works exclusively in healthcare and life sciences. That means a genuine familiarity with the science, the regulatory landscape, and the audiences that different documents are written for — and a track record of getting the work right in each of those contexts.
We engage seriously with the science.
We read the data, understand the mechanism, and work closely with your team to make sure the content is accurate before it's made clear. Good communication in healthcare starts with getting the science right.
The communication follows from the evidence.
We don't impose a narrative on the data — we develop one from it. That keeps the work credible under scrutiny, whether the reviewer is a medical affairs director, a regulator, or an investor running their own diligence.
Structured for how regulated environments work.
Healthcare documents go through medical, legal, and regulatory review before they're published. We write with that process in mind from the first draft, so your reviewers can focus on the substance rather than the structure.
About
Meridian Bridge was built on a straightforward observation: the gap between what the science says and what audiences understand is where good research loses traction. Regulatory submissions stall, investment conversations go quiet, and patients disengage — not because the underlying work isn't strong, but because the communication around it isn't doing its job.
The studio was founded by someone whose background sits at the intersection of academic research, behavioural science, and communications. That combination means a genuine comfort with complex scientific material — the ability to read it carefully, engage with it accurately, and shape it for the audience that needs to understand it. It's a different skill from producing the science, and a necessary complement to it.
The team follows the field closely, including through independent writing on medtech, neurotech, and health technology at Substack.
We work with clients globally, across healthcare, life sciences, and adjacent sectors.
How we work
01
We start with a 30-minute call to understand the project — the audience, the context, the regulatory environment, and what success looks like. There's no charge for this, and no obligation to proceed.
02
Before any work begins, you receive a written proposal covering scope, pricing, timeline, and revision rounds. This keeps expectations clear on both sides and gives the project a solid foundation.
03
A first draft within the agreed timeline, followed by structured revision rounds designed around how your organisation reviews and signs off content. We stay involved until the document is right.
Selected work
Investor & pipeline
Clinical and pipeline section for a Series B fundraising deck, written for a clinical-stage biotechnology company preparing for an institutional raise. The brief required translating a complex inflammatory disease mechanism into a narrative that would hold up with specialist biotech investors and generalist institutional allocators alike.
Regulatory & patient-facing
Public-facing summary of a large vaccine effectiveness study, written for an ethics-committee submission and funder report. Required meeting a grade 8–10 reading level across a lay audience, while accurately representing the statistical findings of a Lancet-published paper.
Regulatory & patient-facing
PIL for a prescription medication, written for regulatory submission and patient-facing packaging. Drafted to a grade 6–8 reading level, back-translatable into multiple languages, and structured to meet plain-language guidance from the relevant medicines authority.
Regulatory & patient-facing
Key patient-facing sections of an informed consent form for a Phase 2b clinical trial, written for ethics-committee submission. GCP-compliant, structured for back-translation, and written at a reading level that supports genuine understanding rather than procedural sign-off.
Medical & scientific communications
Patient-facing FAQ on a complex HIV treatment concept, written for a pharmaceutical medical affairs team. Designed for distribution through clinic channels and NGO platforms, with accuracy reviewed against current WHO and national treatment guidelines.
Regulatory & patient-facing
Funder report and community feedback summary for a population-based multimorbidity study, published in a peer-reviewed global health journal. Written to satisfy ethics-committee requirements for participant feedback and Wellcome Trust reporting obligations.
Writing samples are available on request.
Contact
If you have a project in mind, we'd be glad to hear about it. A brief note about what you're working on and who it's for is enough to get started. We'll come back to you within one working day.